Publications by authors named "Kalvin Connor"
Clin Pharmacol Drug Dev
April 2024
Article Synopsis
- Etrasimod is a potential oral medication for treating immune-related inflammatory disorders, being tested for its effects on heart electrical activity, specifically the QT interval.
- The study involved healthy adults receiving either etrasimod in varying doses or placebos, with the main focus on its impact on the QT interval measured through electrocardiograms.
- Results showed that etrasimod's impact on the QTc interval was minimal, remaining below 10 milliseconds, and it only caused slight, temporary decreases in heart rate without any significant heart block issues.
View Article and Find Full Text PDF